Cargando…
Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
Because of the high prevalence and associated-mortality of hepatocellular carcinoma (HCC), early diagnosis of the disease is vital for patient survival. In this regard, tumor size is one of the two main prognostic factors for surgical resection, which constitutes the only curative treatment for HCC...
Autores principales: | Ferrín, Gustavo, Aguilar-Melero, Patricia, Rodríguez-Perálvarez, Manuel, Montero-Álvarez, José Luis, de la Mata, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403743/ https://www.ncbi.nlm.nih.gov/pubmed/25926760 http://dx.doi.org/10.2147/HMER.S50161 |
Ejemplares similares
-
Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis
por: Ferrín, Gustavo, et al.
Publicado: (2015) -
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
por: Amado, Víctor, et al.
Publicado: (2018) -
Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
por: Ferrín, Gustavo, et al.
Publicado: (2020) -
AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 Expression
por: González-Rubio, Sandra, et al.
Publicado: (2016) -
Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation
por: Amado, Víctor, et al.
Publicado: (2021)